These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
212 related articles for article (PubMed ID: 28774656)
1. Plasma apolipoprotein E levels and risk of dementia: A Mendelian randomization study of 106,562 individuals. Rasmussen KL; Tybjærg-Hansen A; Nordestgaard BG; Frikke-Schmidt R Alzheimers Dement; 2018 Jan; 14(1):71-80. PubMed ID: 28774656 [TBL] [Abstract][Full Text] [Related]
2. Plasma levels of apolipoprotein E and risk of dementia in the general population. Rasmussen KL; Tybjaerg-Hansen A; Nordestgaard BG; Frikke-Schmidt R Ann Neurol; 2015 Feb; 77(2):301-11. PubMed ID: 25469919 [TBL] [Abstract][Full Text] [Related]
3. Plasma levels of apolipoprotein E, APOE genotype and risk of dementia and ischemic heart disease: A review. Rasmussen KL Atherosclerosis; 2016 Dec; 255():145-155. PubMed ID: 28340945 [TBL] [Abstract][Full Text] [Related]
4. Serum apolipoprotein E is associated with long-term risk of Alzheimer's disease: The Rotterdam Study. Wolters FJ; Koudstaal PJ; Hofman A; van Duijn CM; Ikram MA Neurosci Lett; 2016 Mar; 617():139-42. PubMed ID: 26876448 [TBL] [Abstract][Full Text] [Related]
5. Body Mass Index and Risk of Alzheimer's Disease: A Mendelian Randomization Study of 399,536 Individuals. Nordestgaard LT; Tybjærg-Hansen A; Nordestgaard BG; Frikke-Schmidt R J Clin Endocrinol Metab; 2017 Jul; 102(7):2310-2320. PubMed ID: 28609829 [TBL] [Abstract][Full Text] [Related]
6. APOE and dementia - resequencing and genotyping in 105,597 individuals. Rasmussen KL; Tybjaerg-Hansen A; Nordestgaard BG; Frikke-Schmidt R Alzheimers Dement; 2020 Dec; 16(12):1624-1637. PubMed ID: 32808727 [TBL] [Abstract][Full Text] [Related]
7. Type-2 diabetes and risk of dementia: observational and Mendelian randomisation studies in 1 million individuals. Thomassen JQ; Tolstrup JS; Benn M; Frikke-Schmidt R Epidemiol Psychiatr Sci; 2020 Apr; 29():e118. PubMed ID: 32326995 [TBL] [Abstract][Full Text] [Related]
8. Plasma levels of apolipoprotein E, APOE genotype, and all-cause and cause-specific mortality in 105 949 individuals from a white general population cohort. Rasmussen KL; Tybjærg-Hansen A; Nordestgaard BG; Frikke-Schmidt R Eur Heart J; 2019 Sep; 40(33):2813-2824. PubMed ID: 31236578 [TBL] [Abstract][Full Text] [Related]
9. The effect of APOE and other common genetic variants on the onset of Alzheimer's disease and dementia: a community-based cohort study. van der Lee SJ; Wolters FJ; Ikram MK; Hofman A; Ikram MA; Amin N; van Duijn CM Lancet Neurol; 2018 May; 17(5):434-444. PubMed ID: 29555425 [TBL] [Abstract][Full Text] [Related]
10. Plasma high-density lipoprotein cholesterol and risk of dementia: observational and genetic studies. Kjeldsen EW; Thomassen JQ; Juul Rasmussen I; Nordestgaard BG; Tybjærg-Hansen A; Frikke-Schmidt R Cardiovasc Res; 2022 Mar; 118(5):1330-1343. PubMed ID: 33964140 [TBL] [Abstract][Full Text] [Related]
12. Apolipoprotein E4 is only a weak predictor of dementia and cognitive decline in the general population. Yip AG; Brayne C; Easton D; Rubinsztein DC; J Med Genet; 2002 Sep; 39(9):639-43. PubMed ID: 12205106 [TBL] [Abstract][Full Text] [Related]
13. No evidence that genetically reduced 25-hydroxyvitamin D is associated with increased risk of ischaemic heart disease or myocardial infarction: a Mendelian randomization study. Brøndum-Jacobsen P; Benn M; Afzal S; Nordestgaard BG Int J Epidemiol; 2015 Apr; 44(2):651-61. PubMed ID: 25981321 [TBL] [Abstract][Full Text] [Related]
14. Absolute 10-year risk of dementia by age, sex and Rasmussen KL; Tybjærg-Hansen A; Nordestgaard BG; Frikke-Schmidt R CMAJ; 2018 Sep; 190(35):E1033-E1041. PubMed ID: 30181149 [TBL] [Abstract][Full Text] [Related]
15. Assessing Genetic Overlap and Causality Between Blood Plasma Proteins and Alzheimer's Disease. Handy A; Lord J; Green R; Xu J; Aarsland D; Velayudhan L; Hye A; Dobson R; Proitsi P; ; J Alzheimers Dis; 2021; 83(4):1825-1839. PubMed ID: 34459398 [TBL] [Abstract][Full Text] [Related]
16. Coffee intake, cardiovascular disease and all-cause mortality: observational and Mendelian randomization analyses in 95 000-223 000 individuals. Nordestgaard AT; Nordestgaard BG Int J Epidemiol; 2016 Dec; 45(6):1938-1952. PubMed ID: 28031317 [TBL] [Abstract][Full Text] [Related]
17. Low-density lipoprotein cholesterol and risk of gallstone disease: a Mendelian randomization study and meta-analyses. Stender S; Frikke-Schmidt R; Benn M; Nordestgaard BG; Tybjærg-Hansen A J Hepatol; 2013 Jan; 58(1):126-33. PubMed ID: 22922093 [TBL] [Abstract][Full Text] [Related]
18. A Genetic Validation of the Neurodegeneration Biomarkers Tau-A and Tau-C - A Mendelian Randomization Study. Axelsen TM; Bager C; Bihlet A; Karsdal MA; Henriksen K; Tang MHE J Prev Alzheimers Dis; 2023; 10(3):536-542. PubMed ID: 37357295 [TBL] [Abstract][Full Text] [Related]
19. Plasma levels of apolipoprotein E and risk of ischemic heart disease in the general population. Rasmussen KL; Tybjærg-Hansen A; Nordestgaard BG; Frikke-Schmidt R Atherosclerosis; 2016 Mar; 246():63-70. PubMed ID: 26761769 [TBL] [Abstract][Full Text] [Related]
20. Prospective Belgian study of neurodegenerative and vascular dementia: APOE genotype effects. Engelborghs S; Dermaut B; Goeman J; Saerens J; Mariën P; Pickut BA; Van den Broeck M; Serneels S; Cruts M; Van Broeckhoven C; De Deyn PP J Neurol Neurosurg Psychiatry; 2003 Aug; 74(8):1148-51. PubMed ID: 12876259 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]